CIK: 0001536562 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 9, 2017
Total Value ($000): $120,385 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 200,000 | $47,148 | 39.2% | — | — | Put | 78462F103 |
| KHC | KRAFT HEINZ CO | 506,888 | $46,030 | 38.2% | $59.21 | +1.2% | COM | 500754106 |
| BUD | ANHEUSER BUSCH INBEV SA/NV | 109,700 | $12,041 | 10.0% | $106.50 | — | SPONSORED ADR | 03524A108 |
| EWZ | ISHARES | 100,000 | $3,746 | 3.1% | — | — | Call | 464286400 |
| INCY | INCYTE CORP | 15,188 | $2,030 | 1.7% | $94.43 | +34.8% | COM | 45337C102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 21,624 | $1,898 | 1.6% | $85.05 | +4.6% | COM | 09061G101 |
| — | CELGENE CORP | 14,131 | $1,758 | 1.5% | $99.79 | — | COM | 151020104 |
| UNH | UNITEDHEALTH GROUP INC | 9,772 | $1,603 | 1.3% | $121.60 | +16.9% | COM | 91324P102 |
| — | ALEXION PHARMACEUTICALS INC | 9,245 | $1,121 | 0.9% | $149.27 | — | COM | 015351109 |
| LLY | LILLY ELI & CO | 7,969 | $670 | 0.6% | $63.99 | +8.7% | COM | 532457108 |
| REGN | REGENERON PHARMACEUTICALS | 1,179 | $457 | 0.4% | $398.98 | -7.6% | COM | 75886F107 |
| — | TESARO INC | 2,860 | $440 | 0.4% | $142.07 | — | COM | 881569107 |
| — | SEATTLE GENETICS INC | 6,433 | $404 | 0.3% | $52.99 | — | COM | 812578102 |
| EWZ | ISHARES | 10,000 | $375 | 0.3% | — | — | Put | 464286400 |
| VRTX | VERTEX PHARMACEUTICALS INC | 3,339 | $365 | 0.3% | $89.66 | -1.8% | COM | 92532F100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 6,903 | $299 | 0.2% | $44.87 | -4.5% | COM | 64125C109 |